Acquired Resistance to FGFR Inhibitor in Diffuse-Type Gastric Cancer through an AKT-Independent PKC-Mediated Phosphorylation of GSK3β.
Lau WM, Teng E, Huang KK, Tan JW, Das K, Zang Z, Chia T, Teh M, Kono K, Yong WP, Shabbir A, Tay A, Phua NS, Tan P, Chan SL, So JBY.
Lau WM, et al. Among authors: das k.
Mol Cancer Ther. 2018 Jan;17(1):232-242. doi: 10.1158/1535-7163.MCT-17-0367. Epub 2017 Oct 4.
Mol Cancer Ther. 2018.
PMID: 28978722